telehealth compound tirzepatide TrimRx Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access led and built for women Fifty 410 Tirzepatide Review 2026

In a Mayo Clinic study presented at an annual meeting of the Endocrine Society in July 2025, researchers found that, over 18 months, 40 postmenopausal women who combined the GLP-1 drug tirzepatide (used in Mounjaro and Zepbound) with hormone therapy lost an average of 17 percent of their body weight

Compared to other weight loss medications or treatments, semaglutide has shown promising results in clinical trials

But while these two peptides can have similar effects, they work in slightly different ways

Tirzepatide (Zepbound) Weight Loss Treatment in Estero, Florida Metabolic Health Transparent Pricing Upfront honest pricing for top quality care We accept hundreds of insurance plans And many more